Viking Therapeutics (VKTX) Q4 2024 Earnings

Oct 23Confirmed
Q4 2023
Q1 2024
Q3 2024
Q4 2024
-0.28
-0.25
-0.23
-0.2

Details

Expected EPS
-0.242875
Actual EPS
-0.22
Surprise EPS
0.02
Surprise Percent
+9.42%

Description

⁨Viking Therapeutics⁩ (⁦VKTX⁩) has reported earnings of ⁦-0.22⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts